Krystal Biotech
KRYS
KRYS
45 hedge funds and large institutions have $129M invested in Krystal Biotech in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
96% more funds holding
Funds holding: 23 → 45 (+22)
18.28% more ownership
Funds ownership: 24.75% → 43.03% (+18%)
Holders
45
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.9M | |
| 2 | +$10.2M | |
| 3 | +$6.96M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$6.75M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.31M |
Top Sellers
| 1 | -$2.48M | |
| 2 | -$720K | |
| 3 | -$403K | |
| 4 |
Renaissance Technologies
New York
|
-$183K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$31.3K |